445 filings
8-K
COSM
Cosmos Health Inc
25 Apr 24
Entry into a Material Definitive Agreement
5:23pm
8-K
COSM
Cosmos Health Inc
19 Apr 24
Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K
5:00pm
NT 10-K
COSM
Cosmos Health Inc
2 Apr 24
Notice of late annual filing
4:30pm
8-K
COSM
Cosmos Health Inc
22 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:25pm
424B3
COSM
Cosmos Health Inc
7 Mar 24
Prospectus supplement
4:31pm
424B3
929u0wwcj4i49j 7m
29 Feb 24
Prospectus supplement
4:33pm
4
ukh0mwjxtz1z9
21 Feb 24
Cosmos Health / Grigorios Siokas ownership change
10:21am
424B3
csywch5c9drk0lhyk pq
15 Feb 24
Prospectus supplement
4:05pm
SC 13G
m99rilp52738ey6y
14 Feb 24
Cosmos Health / ARMISTICE CAPITAL ownership change
3:33pm
EFFECT
9238syl3
9 Feb 24
Notice of effectiveness
12:15am
CORRESP
fh06xm
6 Feb 24
Correspondence with SEC
12:00am
UPLOAD
76cv9oaj
5 Feb 24
Letter from SEC
12:00am
8-K
l2y0m0ukuhj pm9aj
22 Jan 24
Cosmos Health Bolsters Presence in $400Bn+ Global Generic Drugs Market with $3.5M Acquisition of 10-Drug Portfolio
4:19pm
8-K/A
cgpbi x8j2wawby
29 Dec 23
Entry into a Material Definitive Agreement
5:00pm
8-K
aw8sa ixyld9pwg
29 Dec 23
Cosmos Health Set for Substantial Growth From Acquisitions Completed in 2023
6:02am
4
pzlywncpa6j1ef v7je
22 Dec 23
Cosmos Health / Anastasios Aslidis ownership change
4:05pm
8-K
l4qlym0 41
28 Nov 23
Departure of Directors or Certain Officers
4:05pm
8-K
006duiz
22 Nov 23
Cosmos Health Reports Q3 2023 Results; Revenue Increased 7% YoY, Total Assets Reached Record $71.5M with Stockholders' Equity of $44.2M or $3.4/Share
9:30am